MIR4322

Across TCGA pan-cancer cohorts, MIR4322 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated MIR4322 data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher MIR4322 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated MIR4322 expression acts as an unfavorable survival marker, although some lineages such as HNSC and ESCA show a favorable association.

HNSC, KIRP, and KICH are the cancer types where MIR4322 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Tertile	IV	0.631	0.279	<.001	111	view →
KIRP	OS	Tertile	All	0.287	0.741	<.001	99	view →
KICH	DFS	Tertile	All	0.043	0.971	<.001	69	view →
BLCA	DFS	Quartile	All	0.216	0.379	.003	59	view →
LIHC	DFS	Tertile	All	0.433	0.568	.006	43	view →
ESCA	OS	Tertile	All	0.734	0.428	.002	39	view →
BRCA	DFS	Tertile	All	0.570	1.000	.033	36	view →
COAD	OS	Tertile	IV	0.042	0.679	<.001	18	view →
UCS	OS	Tertile	IV	0.756	0.224	.024	16	view →
READ	DFS	Tertile	IV	1.000	0.498	.021	15	view →
LUSC	OS	Quartile	All	0.577	0.689	.019	10	view →
MESO	OS	Quartile	All	0.654	0.399	.012	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

MIR4322–HNSC (DFS)

Open the HNSC breakdown →